ArticleFrontiers in immunology2022

HDAC Inhibition as Potential Therapeutic Strategy to Restore the Deregulated Immune Response in Severe COVID-19.

Chiara Ripamonti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.